WOCKPHARMA
NSEPrice History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Trend
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Price Action
Support & Resistance Levels
Volume Analysis
Stop Loss Levels
Fixed Risk
Technical Levels
Moving Averages
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹721 Cr | ₹646 Cr | ₹738 Cr | ₹888 Cr |
| Net Profit | ₹14 Cr | ₹-25 Cr | ₹-90 Cr | ₹59 Cr |
| EPS | ₹0.91 | — | ₹-5.53 | ₹3.61 |
| Operating Profit | ₹136 Cr | ₹75 Cr | ₹-5 Cr | ₹192 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 21 Jun 2024 | Annual General Meeting | AGM |
| 07 Aug 2023 | Annual General Meeting | AGM |
| 08 Mar 2022 | Rights 3:10@ Premium Rs 220 Per Share | RIGHTS_ISSUE |
| 23 Jul 2021 | Annual General Meeting | AGM |
| 24 Jul 2020 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for WOCKPHARMA
View AllAegis Logistics Ltd leads gainers in 'A' group
Blue Jet Healthcare Ltd, Wockhardt Ltd, DOMS Industries Ltd and Apar Industries Ltd are among the other gainers in the BSE's 'A' group today, 11 June 2026.
Wockhardt Ltd eases for fifth straight session
Wockhardt Ltd is quoting at Rs 1874, down 0.72% on the day as on 13:19 IST on the NSE. The stock jumped 18.41% in last one year as compared to a 6.94% slide in NIFTY and a 10.46% spurt in the Nifty Pharma index.
Pharma in her DNA, Wockhardt scion ready for deep dive in the US
Zahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacterial infections and is a significant bet for the company. Zaynich's US approval marks a major breakthrough after decades without new antibiotics. Zahabiya is focused on hospital penetration, physician advocacy, and demonstrating economic value to healthcare systems.